Drug profile · INN
formoterol fumarate dihydrate
RILTRAVA AEROSPHERE
formoterol fumarate dihydrate (RILTRAVA AEROSPHERE) is a beta-2 adrenergic receptor agonist.
EMA: approved Respiratory system (R03) R03AL11
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — formoterol fumarate dihydrate
- Class
- Respiratory system (R03)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
formoterol fumarate dihydrate (RILTRAVA AEROSPHERE) is a beta-2 adrenergic receptor agonist.
Key facts
INN formoterol fumarate dihydrate
Brand RILTRAVA AEROSPHERE
Mechanism Beta-2 adrenergic receptor agonist
Target Beta-2 adrenergic receptor
Therapeutic class Respiratory system (R03)
ATC code R03AL11
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is formoterol fumarate dihydrate?
formoterol fumarate dihydrate (RILTRAVA AEROSPHERE) is a beta-2 adrenergic receptor agonist.
What is the brand name for formoterol fumarate dihydrate?
RILTRAVA AEROSPHERE is a marketed brand name for formoterol fumarate dihydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.